The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
114558524 11455852 4 F 1995 20160713 20150903 20160725 EXP US-BAYER-2015-413400 BAYER 64.00 YR A F Y 0.00000 20160725 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
114558524 11455852 1 PS CLIMARA ESTRADIOL 1 Transdermal UNK 150041 20375 TRANSDERMAL PATCH
114558524 11455852 2 SS CLIMARA ESTRADIOL 1 Transdermal UNK 160081 20375 TRANSDERMAL PATCH
114558524 11455852 3 SS CLIMARA ESTRADIOL 1 Transdermal UNK 150041 20375 TRANSDERMAL PATCH

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
114558524 11455852 1 Hot flush
114558524 11455852 2 Migraine
114558524 11455852 3 Hot flush

Outcome of event

Event ID CASEID OUTC COD
114558524 11455852 HO
114558524 11455852 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
114558524 11455852 Application site dryness
114558524 11455852 Application site erosion
114558524 11455852 Application site hypersensitivity
114558524 11455852 Application site rash
114558524 11455852 Application site reaction
114558524 11455852 Application site vesicles
114558524 11455852 Cataract
114558524 11455852 Clostridium difficile infection
114558524 11455852 Device adhesion issue
114558524 11455852 Device issue
114558524 11455852 Device use issue
114558524 11455852 Drug dose omission
114558524 11455852 Drug level decreased
114558524 11455852 Headache
114558524 11455852 Inappropriate schedule of drug administration
114558524 11455852 Infection
114558524 11455852 Migraine
114558524 11455852 Oesophageal operation
114558524 11455852 Off label use
114558524 11455852 Pancreatic disorder
114558524 11455852 Pancreatic fibrosis
114558524 11455852 Pancreatic steatosis
114558524 11455852 Pancreatitis relapsing
114558524 11455852 Pre-existing condition improved
114558524 11455852 Product adhesion issue
114558524 11455852 Product formulation issue
114558524 11455852 Product use issue
114558524 11455852 Scar
114558524 11455852 Therapeutic response unexpected
114558524 11455852 Withdrawal syndrome

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
114558524 11455852 1 1989 0
114558524 11455852 3 20150723 0